A multisociety Delphi consensus statement on new fatty liver disease nomenclature
2023 · Hepatology · 2,642 citations
https://doi.org/10.1097/hep.0000000000000520
F
Fasiha Kanwal
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
403
Papers
23.4K
Citations
72
h-index
165
i10-index
Fasiha Kanwal is an academic researcher from Michael E. DeBakey VA Medical Center. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Liver Disease and Transplantation & Hepatocellular Carcinoma Treatment and Prognosis. The author has an h-index of 72, co-authored 343 publications.
ORCID: 0000-0001-6715-3966Papers by this author
worksA multisociety Delphi consensus statement on new fatty liver disease nomenclature
2023 · Journal of Hepatology · 2,472 citations
https://doi.org/10.1016/j.jhep.2023.06.003
Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review
2012 · Clinical Gastroenterology and Hepatology · 758 citations
https://doi.org/10.1016/j.cgh.2012.10.001
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
2023 · Annals of Hepatology · 734 citations
https://doi.org/10.1016/j.aohep.2023.101133
Advancing the global public health agenda for NAFLD: a consensus statement
2021 · Nature Reviews Gastroenterology & Hepatology · 709 citations
https://doi.org/10.1038/s41575-021-00523-4
Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy
2023 · Nature Reviews Clinical Oncology · 681 citations
https://doi.org/10.1038/s41571-023-00825-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat